AP65-1 Gene Assay for Specific Trichomonas Vaginalis Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic methods for Trichomonas vaginalis, such as wet mount and pap smear, are less sensitive and time-consuming, while newer methods like rapid antigen testing and PCR are not widely used, necessitating the development of more reliable and accurate detection techniques.

Innovation Solution

The use of oligonucleotide probes targeting the highly conserved AP65-1 gene of Trichomonas vaginalis for detection through amplification methods like SDA and Taqman® real-time PCR, which amplify and detect specific regions of the gene to identify the presence of the organism.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If wet mount or pap smear methods are used for detection, then the diagnostic process is simpler, but the sensitivity and accuracy of detection is reduced

Engineering Contradiction:
Improvesimplicity of diagnostic processVSAvoidsensitivity of detection
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent replaces mechanical/optical detection methods (wet mount microscopy, pap smear visual inspection) with molecular biology methods (PCR amplification, hybridization detection). This substitution enables detection of T. vaginalis DNA at much lower concentrations, dramatically improving sensitivity while maintaining operational simplicity through standardized test protocols.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces oligonucleotide probes as intermediaries that specifically bind to T. vaginalis DNA sequences. These probes act as mediators between the target DNA and detection systems, enabling highly specific and sensitive detection through hybridization signals that can be amplified and detected with high precision.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If newer methods like rapid antigen testing and PCR are used, then the sensitivity of detection is improved, but the complexity of the diagnostic system increases

Engineering Contradiction:
Improvesensitivity of detectionVSAvoidcomplexity of diagnostic system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex PCR and hybridization process into distinct, standardized components: DNA extraction, PCR amplification with specific primers, and hybridization detection with labeled probes. This segmentation allows each step to be optimized independently and facilitates automation, reducing overall system complexity while maintaining high sensitivity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs specific parameter optimizations including primer sequences targeting conserved regions of the AP65 gene, controlled annealing temperatures for hybridization, and fluorescent labeling parameters. These parameter changes enable highly sensitive detection while standardizing the protocol to reduce operational complexity.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If conventional detection methods are used, then the risk of false positives and cross-reactivity is lower due to simplicity, but the reliability and accuracy of diagnosis is reduced

Engineering Contradiction:
Improveaccuracy of diagnosisVSAvoidcomplexity of detection method
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent designs oligonucleotide probes that target specific local regions of the T. vaginalis genome, particularly conserved sequences in the AP65 gene. This localized targeting ensures high specificity by binding only to the intended target sequence, minimizing false positives and cross-reactivity with other organisms while maintaining diagnostic reliability.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent replaces non-specific mechanical mixing and visual inspection with molecularly specific hybridization reactions. The complementary base pairing mechanism provides inherent specificity, where only perfectly or near-perfect matches between probe and target DNA will stabilize, eliminating cross-reactivity issues present in conventional methods.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides a highly sensitive and specific method for detecting Trichomonas vaginalis, minimizing false positives and reducing the risk of cross-reactivity with other organisms, thereby enhancing diagnostic accuracy.

Implementation Method 1

The use of oligonucleotide probes targeting the highly conserved AP65-1 gene of Trichomonas vaginalis for detection

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

amplification methods like SDA and Taqman® real-time PCR, which amplify and detect specific regions of the gene

Methodology Applied
Scientific EffectPCR amplification:

Data Source

PatentUS20260085365A1Assay for trichomonas vaginalis by amplification and detection of trichomonas vaginalis AP65-1 gene
Publication Date: 2026.03.26 BECTON DICKINSON & CO
  • US20260085365A1 patent drawing
  • US20260085365A1 patent drawing
  • US20260085365A1 patent drawing

AI summary

A region of the Trichomonas vaginalis AP65-1 gene has been identified which is useful for performing amplification assays to determine specifically whether T. vaginalis is present in the sample being tested. Oligonucleotides useful for performing thermal Strand Displacement Assay (tSDA) reactions on this gene are disclosed. The disclosed oligonucleotides can be used in an assay which is specific for multiple strains of T. vaginalis and which does not show cross reactivity with the genomes of other microorganisms or with human DNA.